Congratulations! Great Bay Bio was awarded as a high-tech enterprise again

Created on:2020-12-24 10:34


December 24th,2020 Press Release


Congratulations! Great Bay Bio was awarded as a high-tech enterprise again

[2020/12/3, Dongguan]Recently, Dongguan Taili Biotech Co.,Ltd., a subsidiary of Great Bay Bio, was awarded as High-tech Enterprise again.

“High-tech enterprise” is a national honor, which refers to the enterprise that continuously carries out research and development and transformation of technical achievements within the "High-tech fields supported by the State", forms the core independent intellectual property rights of the enterprise, and carries out business activities based on this, and transforms significant high-tech achievements into productivity at a technical level that is domestic leading or international advanced, and is a knowledge-intensive and technology-intensive economic entity. High and new technology enterprises are re-identified every three years, and following the identification in 2017, Great Bay Bio was again recognized as a high-tech enterprise.


Great Bay Bio always insists on innovation-driven R&D as its core competitiveness, and applies artificially intelligent biotechnology to cell therapy, molecular diagnostics, clinical diagnostics and other blue ocean markets to make drug development faster, less costly and less risky. The continuous award of high-tech enterprise is the affirmation and praise of the relevant departments and people from all walks of life to the technological innovation ability, high-end technology openness and innovation consciousness of Great Bay Bio, which further highlights the advantages of Great Bay Bio as a strategic new backbone enterprise with high technology and high growth supported by the state, which will further enhance the brand image of the enterprise, increase the market share of the products, and it has laid a solid foundation for further enhancing the brand image of the enterprise, improving the market share of products, capital value, and enjoying the preferential policies of tax relief for high-tech enterprises.


About Great Bay Bio

Headquartered in Hong Kong, GBB is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to CMC (Chemistry, Manufacturing, Control) for development of biopharmaceuticals and other blue ocean bio-products (such as cell therapy), ultimately solving numerous pain points of CMC development, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has obtained massive data from conventional biologics development in its 3100 m2 CMC facilities in Dongguan, PRC. With over RMB 300M investment, the facilities bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created the intelligent centralized database, where deep learning is being performed to create next generation AI-enabled CMC platforms. To learn more, please visit


PR Contact: Miss Liu 


Home    News    Congratulations! Great Bay Bio was awarded as a high-tech enterprise again